期刊文献+

BMP-2基因在先心病肺动脉高压患儿中的突变研究 被引量:1

Bone morphogenetic proteins 2(BMP-2)mutations in Chinese children with Pulmonary arterial hypertens caused by congenital heart defect
原文传递
导出
摘要 目的研究先天性心脏病引起的肺动脉高压中国患儿中是否存在BMP-2基因的错义突变。方法在18个先心病肺动脉高压(PAH)患儿及250个健康儿童中,对BMP-2的整个编码区及所有剪切位点进行序列分析。结果在18个PAH患儿中发现了一个有意义的潜在的致病突变(c.T326C,p.V109A)。该错义突变位于BMP-2基因的保守序列,其编码的氨基酸改变可能影响BMP-2功能。结论本实验在先心病引起的肺动脉高压中国患儿中发现了一个潜在的致病突变,BMP-2基因可能是中国人肺动脉高压发病过程的一个潜在候选基因。 Objective:The aim of this study was to identify potential pathological mutations in the BMP-2 gene in Chinese children with pulmonary artery hypertension(PAH)caused by congenital heart disease(CHD). Methods:Sequence analysis of the entire coding region and all splice site of BMP-2 gene were performed in 18 PAH patients caused by CHD and 250 healthy controls. Results:We discovered one novel potential pathogenic variant(c. T326 C,p. V109A)in 18 PAH patients. This missense mutation was located in the BMP-2 conserved residue and the amino acid change may affect the function of BMP-2. Conclusions:The present study identified a potential pathogenic variation in Chinese PAH patients caused by CHD. BMP-2 gene is a possible potential candidate gene in PAH development in Chinese population.
出处 《中国优生与遗传杂志》 2015年第12期15-17,F0002,共4页 Chinese Journal of Birth Health & Heredity
基金 国家自然科学基金 项目编号:81300131 国家自然科学基金 项目编号81460282 81260299 博士点基金 项目编号:20131107120020 青海省应用基础研究资助项目 项目编号:2013-Z-744
关键词 BMP-2基因 先天性心脏病 肺动脉高压 突变 BMP-2 Pulmonary arterial hypertension Congenital heart disease Mutation
  • 相关文献

参考文献23

  • 1Hoffman JI, Kaplan S. The incidence of congenital heart disease[J]. J Am Coil Cardiol, 2002,39:1890-1900.
  • 2荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:117
  • 3Li W, Dunmore BJ, Morrell NW. Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension[J]. Proc Am Thorac Soc, 2010, 7 (6) :395-398.
  • 4Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation :molecular clones and activities[J]. Science, 1988, 242 : 1528-34.
  • 5Yuasa S, Itabashi Y, Koshimizu U, et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells[J]. Nature Biotechnol, 2005,23 : 607-11.
  • 6Schultheiss TM, Burch JB, Lassar AB. A role for bone morphogenetic proteins in the induction of cardiac myogenesis[J]. Genes Dev, 1997, 11:451-62.
  • 7Deng Z, Morse JH, Slager S, et al. Familial pulmonary hypertension (gene PPH1 )is caused by mutations in the bone morphogenetic protein reeeptor-II gene[J]. Am J Hum Genet, 2000,67:737-4.
  • 8Machado RD, Pauciulo MW, Thomson JR, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension[J]. Am J Hum Genet, 2001,68 : 92-102.
  • 9Thomson JR, Machado RD, Pauciulo MW, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-IIBMPR2, a receptor member of the TGF-family[J]. J Med Genet, 2000, 37:741-75.
  • 10Roberts KE, McElroy JJ. BMPR-2 mutations in pulmonary arterial hypertension with congenital heart disease[J]. Eur Respir J, 2004, 24:371-4.

二级参考文献133

  • 1荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量:98
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35:979-987.
  • 3[14]Foletta VC,Ljm MA,Soosariajah J,et al.Direct signaling by the BMP type Ⅱ receptor via he cytoskeletal regulator LIMK1[J].J Cell Biol,2003,162(6):1089-1098.
  • 4[15]Du L,Sullivan CC,Chu D,et al.Signaling molecules in nonfamilial pulmonary hypertension[J].N Engl J Med,2003,348(6):500-509.
  • 5[1]Simonneau G,Galie N,Rubin LJ,et al.Clinical classification of pulmonary hypertension[J].J Am Coll Cardiol,2004,43(12 Suppls):5S-12S.
  • 6[2]Humbert M,Morrell NW,Areher SL,et al.Cellular and molecular pathobiology of pulmonary arterial hypertension[J].J Am Coll Cardiol,2004,43(12 Suppls):13S-24S.
  • 7[3]Spinella-Jaegle S,Roman-Roman S.Faueheu C,et al.Opposite effects of bone morphogenetic protem-2 and transforming growth factor beta 1 on osteoblast differentiation[J].Bone,2001,29(4):323-330.
  • 8[4]Wong GA,Tang V,El-Sabeawy F,et al.BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21[J].Am J Physiol Endocriol Metab,2003,284(5);E972-E979.
  • 9[5]Deng Z,Morse JH,Slager SL,et al.Familial primary pulmonary hypertension(gene PPH1)is caused by mutations in the bone morphogenetic protein receptor-Ⅱ gene[J].Am J Hum Genet,2000,68(3):737-744.
  • 10[6]Thomson JR,Machado RD,Pauciulo MW,et al.Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-Ⅱ,a receptor member of the TGF-beta family[J].J Med Genet,2000,37(10):741-745.

共引文献128

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部